Coronary Disease/Myocardial Infarction
RSSArticles
-
Clinical Briefs in Primary Care Supplement
-
Current Drug Usage in Atrial Fibrillation
This paper reviews drug therapy in patients with atrial fibrillation in the Medicare population. The author extracted a 5% sample of Medicare beneficiaries who were enrolled in Medicare Part D. -
PCI Outcomes in Women vs Men
Percutaneous coronary intervention (PCI) is performed in more than 600,000 patients annually in the United States, and women make up approximately one-third of this population. -
Is There a Benefit to Cardiac Resynchronization Therapy in Patients with a Narrow QRS and Echocardiographic Dyssychrony?
-
Esmolol in Septic Shock
-
Are Eligible Patients in the Community Receiving ICDs?
-
Embolic Risk in Endocarditis
-
Colchicine in Acute Pericarditis
-
Biventricular vs RV Pacing for AV Block in Heart Failure
The Biventricular vs Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block (BLOCK HF) trial tested the hypothesis that biventricular pacing (cardiac resynchronization therapy [CRT]) would be superior to right ventricular pacing in patients with mild-to-moderate heart failure, left ventricular systolic dysfunction, and an indication for full-time ventricular pacing. -
Digoxin and Mortality in Atrial Fibrillation
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) trial was completed more than 10 years ago.